Blood Pressure After PREeclampsia/HELLP by SELF Monitoring Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT03228082

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose device feasibility
Phase
Not applicable
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03228082
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany, Netherlands (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03228082. Randomized; no masking; primary purpose device feasibility. Start 2017-07-13 (actual); primary completion 2019-12-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Blood Pressure After PREeclampsia/HELLP by SELF Monitoring Study
Acronym
BP-PRESELF
Condition
Preeclampsia
Condition
Cardiovascular Risk Factor
Condition
Cardiovascular Diseases
Condition
Hypertension
Intervention (Device)
Home Blood Pressure Monitoring (HBPM)
Lead sponsor
Radboud University Medical Center (class: other)
Collaborator
Interreg (class: other)

Record details

Record id
cardio:ct-nct03228082
Content hash
6026bd3cc3ec402921a4dd31b6cd450883595eaa3e6563b67f1a04e00d2be656